Long-term use of Adderall for weight loss can lead to a rebound effect , where weight or body mass index returns to pre-prescription levels once the drug is discontinued, making it a less sustainable option
Current UK practice generally allows continuing GLP-1 receptor agonists perioperatively with appropriate risk assessment for gastrointestinal symptoms and aspiration risk
Track these observations and discuss them with your provider
Ultimately, medication management should always occur through collaborative decision-making with qualified healthcare providers who can assess individual patient factors, monitor for adverse effects, and adjust therapy using evidence-based approaches rather than improvised dose modifications
Additionally, disclose your smoking, alcohol consumption, or illegal drug usage to your healthcare provider
This preparation helps create a tidy environment, significantly reducing the risk of contamination during the combination of the substance